October 21, 2015 | Gordian Surgical, a portfolio company of Trendlines Medical, recently raised $1 million, including an investment from Virtus Inspire Ventures, a Chinese venture capital firm. Gordian intends to use the funds to complete American (FDA) and European (CE) regulatory processes, begin in vivo trials, and prepare for market penetration. Led by CEO Zvi Pe’er, Gordian has developed an innovative trocar that offers surgeons a simple, economical solution for opening and suturing internal incisions made during laparoscopic surgery.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments